[{"Assets_0_Q1_USD":"6062707000.0","CIK":"1048477","CommonStockSharesIssued_0_Q1_shares":"184901764.0","CommonStockSharesOutstanding_0_Q1_shares":"184901764.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"0.66","EarningsPerShareDiluted_1_Q1_USD":"0.63","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-45431000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":"120798000.0","NetIncomeLoss_1_Q1_USD":"120798000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q1_USD":"519359000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"4391315000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":"194886000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":"183990000.0","filed":"20220429","footnote":null,"form":"10-Q","fp":"Q1","fy":"2022.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20220331","qtrs":"1","uom":"USD"}]